Literature DB >> 4008333

Nargenicin biosynthesis: late stage oxidations and absolute configuration.

D E Cane, C C Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4008333     DOI： 10.7164/antibiotics.38.423

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  4 in total

1.  Nature as organic chemist.

Authors:  David E Cane
Journal:  J Antibiot (Tokyo)       Date:  2016-07       Impact factor: 2.649

2.  Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells.

Authors:  Cheol Park; Da Hye Kwon; Su Jung Hwang; Min Ho Han; Jin-Woo Jeong; Sang Hoon Hong; Hee-Jae Cha; Su-Hyun Hong; Gi-Young Kim; Hyo-Jong Lee; Suhkmann Kim; Heui-Soo Kim; Yung Hyun Choi
Journal:  Int J Environ Res Public Health       Date:  2019-03-22       Impact factor: 3.390

3.  DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis.

Authors:  Melissa D Chengalroyen; Mandy K Mason; Alessandro Borsellini; Raffaella Tassoni; Garth L Abrahams; Sasha Lynch; Yong-Mo Ahn; Jon Ambler; Katherine Young; Brendan M Crowley; David B Olsen; Digby F Warner; Clifton E Barry Iii; Helena I M Boshoff; Meindert H Lamers; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2022-02-10       Impact factor: 5.084

4.  Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway.

Authors:  Da Hye Kwon; Gi-Young Kim; Hee-Jae Cha; Suhkmann Kim; Heui-Soo Kim; Hye-Jin Hwang; Yung Hyun Choi
Journal:  EXCLI J       Date:  2021-05-28       Impact factor: 4.068
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.